Pharma Equity Group A/S
CSE:PEG
Relative Value
The Relative Value of one
PEG
stock under the Base Case scenario is
0.08
DKK.
Compared to the current market price of 0.104 DKK,
Pharma Equity Group A/S
is
Overvalued by 23%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PEG Competitors Multiples
Pharma Equity Group A/S Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Pharma Equity Group A/S
CSE:PEG
|
127.7m DKK | 0 | -6.1 | -7.9 | -7.9 | |
| DE |
|
Vonovia SE
XETRA:VNA
|
21B EUR | 4 | 7.5 | 22.2 | 26.9 | |
| BM |
|
Hongkong Land Holdings Ltd
SGX:H78
|
18.4B USD | 10.3 | -55.3 | 31.7 | 32.3 | |
| HK |
S
|
Swire Properties Ltd
HKEX:1972
|
143.9B HKD | 8.7 | -36.9 | 21.6 | 21.6 | |
| IL |
|
Azrieli Group Ltd
TASE:AZRG
|
52.7B ILS | 8.7 | 20.2 | 21 | 21.1 | |
| CN |
|
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
|
108.2B HKD | 5.2 | 24.5 | 17.5 | 17.5 | |
| CH |
|
Swiss Prime Site AG
SIX:SPSN
|
10.7B CHF | 17.2 | 29.6 | 36.5 | 37.1 | |
| CN |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
84.7B CNY | 4.7 | 20.1 | 15.5 | 15.5 | |
| SG |
|
Capitaland Investment Ltd
SGX:9CI
|
15.5B SGD | 6.3 | 35.9 | 29.2 | 36.1 | |
| HK |
W
|
Wharf Real Estate Investment Company Ltd
HKEX:1997
|
85.6B HKD | 6.5 | -179.1 | 11.5 | 11.5 | |
| PH |
S
|
SM Prime Holdings Inc
XPHS:SMPH
|
614.4B PHP | 4.3 | 12.5 | 10.1 | 12.3 |